Trade Novavax NVAX

Novavax live chart

instrument_fundamentals

Weekly Search
Weekly
Daily
date Close change Change (%) instr__open High Low

Novavax news

2021 May 11, 13:20

US pre-market: selling unabated

2021 May 06, 08:27

Stocks rally as Fed speakers get back on script, earnings support + Bank of England set to raise forecasts

2021 Feb 28, 07:36

Week Ahead: RBA speaks, US NFPs released & OPEC clash

2020 May 26, 08:04

Leg up: stocks make new ground, travel stocks soar

Latest news

Show more
Liam James 2025 Aug 13, 00:00

RBA Cuts Interest Rates: Analyzing the Implications and Market Expectations

Noah Lee 2025 Aug 13, 00:00

Fed's Response to Labor Market Data Concerns: Navigating Uncertainty

Liam James 2025 Aug 13, 00:00

US CPI July: Does Inflation Data Bolster Fed Rate Cut Expectations?

Noah Lee 2025 Aug 13, 00:00

Berkshire Hathaway's Secret Stock: Is It a $5 Billion Industrial Play?

Ava Grace 2025 Aug 13, 00:00

US Inflation Outlook: Tariffs, Fed Policy, and Gold Price Dynamics

Ava Grace 2025 Aug 13, 00:00

Trump Criticizes Powell, Calls for Rate Cuts Amid Inflation Concerns

Ava Grace 2025 Aug 13, 00:00

US CPI July 2024 Analysis: A Detailed Breakdown

Ava Grace 2025 Aug 12, 03:20

US CPI Data July: A Risky Economic Outlook Unveiled

Info

Spread

0.07

Spread (%)

0.8343 %

Leverage

1:10

Overnight Interest Buy

-0.0597 %

Overnight Interest Sell

-0.0292 %

Currency

USD

Trading Hours

Markets closed

Wednesday

13:31 - 19:59

Monday

13:31-19:59

Tuesday

13:31-19:59

Thursday

13:31-19:59

Friday

13:31-19:59

instr__analysis_statistics

instr__open

---

instr__close

---

instr__52week_range

--- – ---

instr__market_cap

1304248576

instr__shares_outstand

162422000

instr__earnings_date

2019-05-10

instr__dividend_date

2019-05-10

instr__ex_dividend_date

instr__forward_annual_dividend_rate

0

instr__forward_annual_dividend_yield

0

instr__eps

2.22

instrument_learn_more

Novavax Novavax Inc
Novavax, Inc., a biotechnology company, engages in the discovering, developing, and commercializing vaccines to protect against serious infectious diseases in the United States, Europe, and internationally. The company offers vaccine platform that combines a recombinant protein approach, nanoparticle technology, and its patented Matrix-M adjuvant to enhance the immune response. The company is commercializing a COVID-19 vaccine, NVX-CoV2373 under the brand names of Nuvaxovid, Covovax, and Novavax COVID-19 Vaccine, adjuvanted for adult and adolescent populations as a primary series and for both homologous and heterologous booster indications. It also developing R21/Matrix-M adjuvant malaria vaccine. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.
Markets.com Bonus Trading

related_instruments

view_all_instruments

latest_education_articles

Show more
Trustpilot